Mortality after in-hospital cardiac arrest in patients with COVID-19: A systematic review and meta-analysis.


Journal

Resuscitation
ISSN: 1873-1570
Titre abrégé: Resuscitation
Pays: Ireland
ID NLM: 0332173

Informations de publication

Date de publication:
07 2021
Historique:
received: 20 02 2021
revised: 21 04 2021
accepted: 27 04 2021
pubmed: 9 5 2021
medline: 25 6 2021
entrez: 8 5 2021
Statut: ppublish

Résumé

To estimate the mortality rate, the rate of return of spontaneous circulation (ROSC) and survival with favorable neurological outcome in patients with COVID-19 after in-hospital cardiac arrest (IHCA) and attempted cardiopulmonary resuscitation (CPR). PubMed, EMBASE, Web of Science, bioRxiv and medRxiv were surveyed up to 8th February 2021 for studies reporting data on mortality of patients with COVID-19 after IHCA. The primary outcome sought was mortality (in-hospital or at 30 days) after IHCA with attempted CPR. Additional outcomes were the overall rate of IHCA, the rate of non-shockable presenting rhythms, the rate of ROSC and the rate of survival with favorable neurological status. Ten articles were included in the systematic review and meta-analysis, for a total of 1179 COVID-19 patients after IHCA with attempted CPR. The estimated overall mortality rate (in-hospital or at 30 days) was 89.9% (95% Predicted Interval [P.I.] 83.1%-94.2%; 1060/1179 patients; I Although one of three COVID-19 patients undergoing IHCA may achieve ROSC, almost 90% may not survive at 30 days or to hospital discharge.

Identifiants

pubmed: 33964332
pii: S0300-9572(21)00168-4
doi: 10.1016/j.resuscitation.2021.04.025
pmc: PMC8098036
pii:
doi:

Types de publication

Journal Article Meta-Analysis Review Systematic Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

122-129

Commentaires et corrections

Type : CommentIn

Informations de copyright

Copyright © 2021 Elsevier B.V. All rights reserved.

Références

BMJ. 2020 Apr 6;369:m1387
pubmed: 32253197
JAMA. 2020 Apr 28;323(16):1574-1581
pubmed: 32250385
Curr Opin Anaesthesiol. 2021 Feb 1;34(1):40-47
pubmed: 33369933
Circ Cardiovasc Qual Outcomes. 2020 Jul;13(7):e006837
pubmed: 32438836
Resuscitation. 2020 Oct;155:3-5
pubmed: 32707146
BMJ. 2020 May 6;369:m1805
pubmed: 32376595
BMJ. 2020 Mar 29;368:m1282
pubmed: 32224494
N Engl J Med. 2020 Jul 9;383(2):e6
pubmed: 32374958
Resuscitation. 2021 Mar;160:72-78
pubmed: 33515638
Heart Rhythm. 2020 Sep;17(9):1439-1444
pubmed: 32585191
Eur Heart J. 2020 Jun 1;41(32):3045-3054
pubmed: 32562486
Resuscitation. 2020 Jun;151:18-23
pubmed: 32283117
ANZ J Surg. 2003 Sep;73(9):712-6
pubmed: 12956787
Circ Cardiovasc Qual Outcomes. 2020 Nov;13(11):e007303
pubmed: 32975134
JAMA Intern Med. 2021 Feb 1;181(2):279-281
pubmed: 32986117
Eur Heart J. 2021 Mar 14;42(11):1094-1106
pubmed: 33543259
Crit Care Med. 2021 Feb 1;49(2):201-208
pubmed: 33093278
N Engl J Med. 2020 Jun 18;382(25):2478-2480
pubmed: 32302081
Am J Emerg Med. 2020 Nov;38(11):2416-2424
pubmed: 33046293
Heart Rhythm. 2020 Sep;17(9):1463-1471
pubmed: 32387246
Catheter Cardiovasc Interv. 2022 Jan 1;99(1):1-8
pubmed: 33543564
N Engl J Med. 2012 Nov 15;367(20):1912-20
pubmed: 23150959
Resusc Plus. 2020 Dec;4:100054
pubmed: 33403368
Pulmonology. 2020 Jul - Aug;26(4):204-212
pubmed: 32362505
JAMA Cardiol. 2020 Jul 1;5(7):802-810
pubmed: 32211816
Circulation. 2020 Jul 14;142(2):184-186
pubmed: 32330083
BMJ. 2020 Sep 30;371:m3513
pubmed: 32998872
Resuscitation. 2020 Jun;151:189-196
pubmed: 32246986
Circ Arrhythm Electrophysiol. 2020 Nov;13(11):e008890
pubmed: 32991202

Auteurs

Mariachiara Ippolito (M)

Department of Surgical, Oncological and Oral Science (Di.Chir.On.S.), University of Palermo, Italy.

Giulia Catalisano (G)

Department of Surgical, Oncological and Oral Science (Di.Chir.On.S.), University of Palermo, Italy.

Claudia Marino (C)

Department of Surgical, Oncological and Oral Science (Di.Chir.On.S.), University of Palermo, Italy.

Rosa Fucà (R)

Department of Surgical, Oncological and Oral Science (Di.Chir.On.S.), University of Palermo, Italy.

Antonino Giarratano (A)

Department of Surgical, Oncological and Oral Science (Di.Chir.On.S.), University of Palermo, Italy; Department of Anaesthesia, Intensive Care and Emergency, Policlinico Paolo Giaccone, Palermo, Italy.

Enrico Baldi (E)

Cardiac Intensive Care Unit, Arrhythmia and Electrophysiology and Experimental Cardiology, Fondazione IRCCS Policlinico San Matteo, Pavia, Italy; Department of Molecular Medicine, Section of Cardiology, University of Pavia, Pavia, Italy.

Sharon Einav (S)

Intensive Care Unit of the Shaare Zedek Medical Medical Centre and Hebrew University Faculty of Medicine, Jerusalem, Israel.

Andrea Cortegiani (A)

Department of Surgical, Oncological and Oral Science (Di.Chir.On.S.), University of Palermo, Italy; Department of Anaesthesia, Intensive Care and Emergency, Policlinico Paolo Giaccone, Palermo, Italy. Electronic address: andrea.cortegiani@unipa.it.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH